VA
VR Adviser’s Relmada Therapeutics RLMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,518,056
| Closed | -$56.2M | – | 33 |
|
|
2022
Q3 | $56.2M | Sell |
1,518,056
-752,016
| -33% | -$27.8M | 8.67% | 4 |
|
|
2022
Q2 | $43.1M | Hold |
2,270,072
| – | – | 8.49% | 3 |
|
|
2022
Q1 | $61.3M | Hold |
2,270,072
| – | – | 9.93% | 3 |
|
|
2021
Q4 | $51.1M | Buy |
2,270,072
+882,352
| +64% | +$19.9M | 6.99% | 4 |
|
|
2021
Q3 | $36.4M | Hold |
1,387,720
| – | – | 4.67% | 9 |
|
|
2021
Q2 | $44.4M | Buy |
1,387,720
+534,514
| +63% | +$17.1M | 5.39% | 6 |
|
|
2021
Q1 | $30M | Buy |
853,206
+184,766
| +28% | +$6.51M | 3.26% | 12 |
|
|
2020
Q4 | $21.4M | Hold |
668,440
| – | – | 3.15% | 10 |
|
|
2020
Q3 | $25.1M | Hold |
668,440
| – | – | 4.92% | 7 |
|
|
2020
Q2 | $29.9M | Sell |
668,440
-174,374
| -21% | -$7.8M | 7.16% | 4 |
|
|
2020
Q1 | $28.7M | Buy |
+842,814
| New | +$28.7M | 7.79% | 3 |
|